Followers

August 06, 2023

USFDA issues warning letter to Intas Pharma for Sanand plant

The USFDA inspected the manufacturing facility from November 22 to December 2, 2022. A warning letter is issued when the US health regulator finds that a manufacturer has significantly violated its regulations


No comments:

Post a Comment